Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer

Preclinical works have suggested cytotoxic chemotherapies may increase the number of cancer stem cells (CSC) whereas angiogenesis inhibition may decrease CSC proliferation. We developed a proof of concept clinical trial to explore bevacizumab activity on breast CSC. Breast cancer patients requiring...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Med
Prif Awduron: Sabatier, Renaud, Charafe-Jauffret, Emmanuelle, Pierga, Jean-Yves, Curé, Hervé, Lambaudie, Eric, Genre, Dominique, Houvenaeghel, Gilles, Viens, Patrice, Ginestier, Christophe, Bertucci, François, Sfumato, Patrick, Extra, Jean-Marc, Gonçalves, Anthony
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6572380/
https://ncbi.nlm.nih.gov/pubmed/31064127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8050612
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg